John E. Taylor
13Patents
8h-index
10Co-inventors
69Inventor score
Filing activity: Aug 11, 1988 → Aug 7, 2008
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5073541A | Treatment of small cell lung cancer with somatostatin analogs | Human Necessities | 39 | Expired |
| US5552520A | Therapeutic peptide derivatives | Human Necessities | 32 | Expired |
| US5162497A | Bradykinin analogs with non-peptide bond | Human Necessities | 15 | Expired |
| US5569741A | Cyclic octapeptide neuromedin B receptor antagonists | Chemistry; Metallurgy | 13 | Expired |
| US5750646A | Bradykinin analogs with non-peptide bond | Human Necessities | 10 | Expired |
| US5708135A | Cyclic peptide analogs of somatostatin | Emerging Cross-Sectional Technologies | 10 | Expired |
| US5663295A | Opioid peptides | Emerging Cross-Sectional Technologies | 9 | Expired |
| US5462926A | Neuromedin B receptor antagonists which demonstrate selectivity | Chemistry; Metallurgy | 8 | Expired |
| US6001801A | Cyclic peptide analogs of somatostatin | Emerging Cross-Sectional Technologies | 8 | Expired |
| US5091381A | 2H-1,3,4-benzotriazepin-2-ones | Chemistry; Metallurgy | 6 | Expired |
| US4957915A | Benzodiazepine analogs | Chemistry; Metallurgy | 4 | Expired |
| US8871706B2 | Method for inhibiting inflammation and pre-inflammatory cytokine/chemokine expression using a ghrelin analogue | Emerging Cross-Sectional Technologies | 3 | Active |
| US7241737B2 | Urotensin-II agonists and antagonists | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.